DuoResp Spiromax (formoterol budesonide): Reviews and patient testimonials

DuoResp Spiromax 160 micrograms / 4.5 micrograms inhalation powder

DuoResp Spiromax is indicated in adults 18 years of age and older only.

Asthma

DuoResp Spiromax is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:

-in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists.

or

-in patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists.

COPD

Symptomatic treatment of patients with COPD with forced expiratory volume in 1 second (FEV₁) < 70% predicted normal and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.

DuoResp Spiromax 320 micrograms/9 micrograms inhalation powder

DuoResp Spiromax is indicated in adults 18 years of age and older only.

Asthma

DuoResp Spiromax is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:

- in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists.

or

- in patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists.

COPD

Symptomatic treatment of patients with COPD with forced expiratory volume in 1 second (FEV₁) < 70% predicted normal and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.